CMP Pharmaceuticals | CaroSpir®

Providing specialty niche liquids for acute care needs

CMP Pharma develops, manufactures and commercializes specialty pharmaceuticals, focused on niche oral liquid, injectable and topical products that solve unmet patient needs. CaroSpir® (Spironolactone Oral Suspension, 25 mg/5mL) is the first and only FDA-approved oral Suspension of the potassium-sparing diuretic spironolactone.

 
 

 


Resources

CaroSpir Educational Brochure

Download Educational Brochure here.

CaroSpir Full Prescribing Information

Download Full Prescribing Information here.


 

Get More Information About CaroSpir

Please fill out this form.